Compare Chicago Atlantic Real Estate Finance (REFI) With Other Cannabis Stocks
Head-to-head stock comparisons across price, valuation, financials, and growth metrics
Chicago Atlantic Real Estate Finance (REFI)
$12.09
+0.33%
$254.9M
REIT
REIT Sector Peers
All REIT cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.
Top Matchups by Market Cap
Companies closest to Chicago Atlantic Real Estate Finance in market capitalization — the most meaningful head-to-head comparisons.
Cross-Sector Comparisons
Top cannabis companies outside the REIT sector. Compare across different business models and market segments.
Jazz Pharmaceuticals
MCap: $10.99B
Scotts Miracle-Gro
MCap: $3.54B
Curaleaf Holdings
MCap: $1.80B
Turning Point Brands
MCap: $1.73B
Green Thumb Industries
MCap: $1.54B
Comparing REFI in the Cannabis Market
Chicago Atlantic Real Estate Finance (REFI) is a REIT-sector cannabis company trading at $12.09 per share with a market capitalization of $254.9M. Among its REIT peers, REFI ranks #3 by market cap, with trailing twelve-month revenue of $55.4M and a gross margin of 0.0%. The stock has moved +0.33% in the current session, trading on the NASDAQ exchange.
When comparing REFI against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (4.6x), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $49.3M). The comparison tables above allow you to evaluate Chicago Atlantic Real Estate Finance relative to 3 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.
Frequently Asked Questions
How does REFI compare to other REIT stocks?+
What is REFI's biggest competitor?+
Is REFI overvalued compared to its peers?+
Which cannabis stock has better margins than REFI?+
Can I compare REFI to stocks in other cannabis sectors?+
Related Pages
Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.